Allspring Global Investments Holdings, LLC Harrow Health, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.4 Billion
- Q2 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 2,123 shares of HROW stock, worth $106,935. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,123
Previous 75
2730.67%
Holding current value
$106,935
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HROW
# of Institutions
122Shares Held
19.7MCall Options Held
700KPut Options Held
575K-
Opaleye Management Inc. Boston, MA3.99MShares$201 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$137 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$92.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$36.2 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.36B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...